Research progress on bone marrow mesenchymal stem cells in the treatment of steroid-induced osteonecrosis of femoral head

doi:10.11958/20221802

Abstract

Abstract:

The etiology and mechanism of steroid-induced osteonecrosis of femoral head (SONFH) have not been fully elucidated, and effective treatments have not yet emerged. With the application of stem cell therapy technology in various disciplines, the nature and function of stem cells have been extensively studied and applied in the treatment of SONFH. However, stem cell transplantation alone is not effective, and its efficacy can be enhanced by pretransplantation modification. This paper reviews the research progress of bone marrow mesenchymal stem cells in the treatment of SONFH.

Key words: femur head necrosis, mesenchymal stem cells, stem cell transplantation, steroid-induced osteonecrosis of the femoral head, bone marrow mesenchymal stem cell

CLC Number:

R681.802

References 37

[1]	LIN L, YU Y, LIU K, et al. Downregulation of miR-30b-5p facilitates chondrocyte hypertrophy and apoptosis via targeting Runx2 in steroid-induced osteonecrosis of the femoral head[J]. Int J Mol Sci, 2022, 23(19):11275. doi:10.3390/ijms231911275.
[2]	AN F, ZHANG L, GAO H, et al. Variants in RETN gene are associated with steroid-induced osteonecrosis of the femoral head risk among Han Chinese people[J]. J Orthop Surg Res, 2020, 15(1):96. doi:10.1186/s13018-020-1557-3.
[3]	RIEDL M, WITZMANN C, KOCH M, et al. Attenuation of hypertrophy in human MSCs via treatment with a retinoic acid receptor inverse agonist[J]. Int J Mol Sci, 2020, 21(4):1444. doi:10.3390/ijms21041444.
[4]	TAN B, LI W, ZENG P, et al. Epidemiological study based on china osteonecrosis of the femoral head database[J]. Orthop Surg, 2021, 13(1):153-160. doi:10.1111/os.12857.
[5]	XU Y, JIANG Y, WANG Y, et al. LINC00473-modified bone marrow mesenchymal stem cells incorporated thermosensitive PLGA hydrogel transplantation for steroid-induced osteonecrosis of femoral head:A detailed mechanistic study and validity evaluation[J]. Bioeng Transl Med, 2022, 7(2):e10275. doi:10.1002/btm2.10275.
[6]	WANG L, TIAN X, LI K, et al. Combination use of core decompression for osteonecrosis of the femoral head:A systematic review and Meta-analysis using Forest and Funnel Plots[J]. Comput Math Methods Med, 2021, 2021:1284149. doi:10.1155/2021/1284149.
[7]	LU G D, CHENG P, LIU T, et al. BMSC-derived exosomal miR-29a promotes angiogenesis and osteogenesis[J]. Front Cell Dev Biol, 2020, 8:608521. doi:10.3389/fcell.2020.608521.
[8]	CHEN Q, SHOU P, ZHENG C, et al. Fate decision of mesenchymal stem cells:adipocytes or osteoblasts?[J]. Cell Death Differ, 2016, 23(7):1128-1139. doi:10.1038/cdd.2015.168.
[9]	JIANG Y, JAHAGIRDAR B N, REINHARDT R L, et al. Pluripotency of mesenchymal stem cells derived from adult marrow[J]. Nature, 2002, 418(6893):41-49. doi:10.1038/nature00870.
[10]	WANG Z, LI X, YANG J, et al. Single-cell RNA sequencing deconvolutes the in vivo heterogeneity of human bone marrow-derived mesenchymal stem cells[J]. Int J Biol Sci, 2021, 17(15):4192-4206. doi:10.7150/ijbs.61950.
[11]	SUN Y, YUAN Y, WU W, et al. The effects of locomotion on bone marrow mesenchymal stem cell fate:insight into mechanical regulation and bone formation[J]. Cell Biosci, 2021, 11(1):88. doi:10.1186/s13578-021-00601-9.
[12]	YU D, ZHANG S, MA C, et al. CCL3 in the bone marrow microenvironment causes bone loss and bone marrow adiposity in aged mice[J]. JCI Insight, 2023, 8(1):e159107. doi:10.1172/jci.insight.159107.
[13]	FANG S, HE T, JIANG J, et al. Osteogenic effect of tsRNA-10277-loaded exosome derived from bone mesenchymal stem cells on steroid-induced osteonecrosis of the femoral head[J]. Drug Des Devel Ther, 2020, 14:4579-4591. doi:10.2147/DDDT.S258024.
[14]	HE Y, ZOU L. Notch-1 inhibition reduces proliferation and promotes osteogenic differentiation of bone marrow mesenchymal stem cells[J]. Exp Ther Med, 2019, 18(3):1884-1890. doi:10.3892/etm.2019.7765.
[15]	LOWERY J W, ROSEN V. The BMP pathway and its inhibitors in the skeleton[J]. Physiol Rev, 2018, 98(4):2431-2452. doi:10.1152/physrev.00028.2017.
[16]	SOTTILE V, SEUWEN K. Bone morphogenetic protein-2 stimulates adipogenic differentiation of mesenchymal precursor cells in synergy with BRL 49653 (rosiglitazone)[J]. FEBS Lett, 2000, 475(3):201-204. doi:10.1016/s0014-5793(00)01655-0.
[17]	LORIES R J, MONTEAGUDO S. Review article:is Wnt signaling an attractive target for the treatment of osteoarthritis?[J]. Rheumatol Ther, 2020, 7(2):259-270. doi:10.1007/s40744-020-00205-8.
[18]	LAINEZ-GONZALEZ D, SERRANO-LOPEZ J, ALONSO-DOMINGUEZ J M. Understanding the Notch signaling pathway in acute myeloid leukemia stem cells:from hematopoiesis to neoplasia[J]. Cancers (Basel), 2022, 14(6):1459. doi:10.3390/cancers14061459.
[19]	KONG L, ZUO R, WANG M, et al. Silencing microRNA-137-3p,which targets RUNX2 and CXCL12 prevents steroid-induced osteonecrosis of the femoral head by facilitating osteogenesis and angiogenesis[J]. Int J Biol Sci, 2020, 16(4):655-670. doi:10.7150/ijbs.38713.
[20]	BRUDER S P, JAISWAL N, HAYNESWORTH S E. Growth kinetics,self-renewal,and the osteogenic potential of purified human mesenchymal stem cells during extensive subcultivation and following cryopreservation[J]. J Cell Biochem, 1997, 64(2):278-294.
[21]	孙伟, 高福强, 李子荣. 股骨头坏死临床诊疗技术专家共识(2022年)[J]. 中国修复重建外科杂志, 2022, 36(11):1319-1326.
	SUN W, GAO F Q, LI Z R. Expert consensus on clinical diagnosis and treatment technique of osteonecrosis of the femoral head (2022 version)[J]. Chinese Journal of Reparative and Reconstructive Surgery, 2022, 36(11):1319-1326. doi:10.7507/1002-1892.202207134.
[22]	MA J, WANG B, YUE D, et al. Outcomes of conversion THA after failed porous tantalum implant for osteonecrosis of the femoral head:A comparative matched study[J]. Hip Int, 2020, 30(6):703-710. doi:10.1177/1120700019863036.
[23]	KURODA Y, OKUZU Y, KAWAI T, et al. Difference in therapeutic strategies for joint-preserving surgery for non-traumatic osteonecrosis of the femoral head between the United States and Japan:A review of the literature[J]. Orthop Surg, 2021, 13(3):742-748. doi:10.1111/os.12979.
[24]	LEE Y K, LEE B, PARVIZI J, et al. Which osteotomy for osteonecrosis of the femoral head and which patient for the osteotomy?[J]. Clin Orthop Surg, 2019, 11(2):137-141. doi:10.4055/cios.2019.11.2.137.
[25]	KANG J S, SUH Y J, MOON K H, et al. Clinical efficiency of bone marrow mesenchymal stem cell implantation for osteonecrosis of the femoral head:A matched pair control study with simple core decompression[J]. Stem Cell Res Ther, 2018, 9(1):274. doi:10.1186/s13287-018-1030-y.
[26]	WANG S L, HU Y B, CHEN H, et al. Efficacy of bone marrow stem cells combined with core decompression in the treatment of osteonecrosis of the femoral head:A PRISMA-compliant meta-analysis[J]. Medicine (Baltimore), 2020, 99(25):e20509. doi:10.1097/MD.0000000000020509.
[27]	ZHU S, ZHANG X, CHEN X, et al. Comparison of cell therapy and other novel adjunctive therapies combined with core decompression for the treatment of osteonecrosis of the femoral head:A systematic review and Meta-analysis of 20 studies[J]. Bone Joint Res, 2021, 10(7):445-458. doi: 10.1302/2046-3758.107.BJR-2020-0418.R1.
[28]	LIGHTNER A L, REAM J, NACHAND D, et al. Remestemcel-L allogeneic bone marrow-derived mesenchymal stem cell product to treat medically refractory Crohn's colitis:preliminary phase IB/IIA study[J]. Br J Surg, 2022, 109(8):653-655. doi:10.1093/bjs/znac078.
[29]	ZHANG L, XI Y, GUO R, et al. Bone marrow mesenchymal stem cell-mediated radiosensitive promoter-combined sodium iodide symporter for the treatment of breast cancer[J]. Hum Gene Ther, 2022, 33(11/12):638-648. doi:10.1089/hum.2021.144.
[30]	WU Z Y, SUN Q, LIU M, et al. Correlation between the efficacy of stem cell therapy for osteonecrosis of the femoral head and cell viability[J]. BMC Musculoskelet Disord, 2020, 21(1):55. doi:10.1186/s12891-020-3064-4.
[31]	ZHANG F, PENG W, WANG T, et al. Lnc Tmem235 promotes repair of early steroid-induced osteonecrosis of the femoral head by inhibiting hypoxia-induced apoptosis of BMSCs[J]. Exp Mol Med, 2022, 54(11):1991-2006. doi:10.1038/s12276-022-00875-0.
[32]	SHIU S T, LEE W F, CHEN S M, et al. Effect of different bone grafting materials and mesenchymal stem cells on bone regeneration:A micro-computed tomography and histomorphometric study in a rabbit calvarial defect model[J]. Int J Mol Sci, 2021, 22(15):8101. doi:10.3390/ijms22158101.
[33]	HERNANDEZ A, NUNEZ J H, SALLENT A, et al. Core decompression combined with implantation of autologous bone marrow concentrate with tricalcium phosphate does not prevent radiographic progression in early stage osteonecrosis of the hip[J]. Clin Orthop Surg, 2020, 12(2):151-157. doi:10.4055/cios19033.
[34]	HOUDEK M T, WYLES C C, SMITH J H, et al. Hip decompression combined with bone marrow concentrate and platelet-rich plasma for corticosteroid-induced osteonecrosis of the femoral head :mid-term update from a prospective study[J]. Bone Jt Open, 2021, 2(11):926-931. doi:10.1302/2633-1462.211.BJO-2021-0132.R1.
[35]	ZHANG F, PENG W, ZHANG J, et al. P53 and Parkin co-regulate mitophagy in bone marrow mesenchymal stem cells to promote the repair of early steroid-induced osteonecrosis of the femoral head[J]. Cell Death Dis, 2020, 11(1):42. doi:10.1038/s41419-020-2238-1.
[36]	YANG F, XUE F, GUAN J, et al. Stromal-cell-derived factor (SDF) 1-alpha overexpression promotes bone regeneration by osteogenesis and angiogenesis in osteonecrosis of the femoral head[J]. Cell Physiol Biochem, 2018, 46(6):2561-2575. doi:10.1159/000489684.
[37]	ZHANG Y L, ZHU Z Z, ZHANG L C, et al. Lithium chloride prevents glucocorticoid-induced osteonecrosis of femoral heads and strengthens mesenchymal stem cell activity in rats[J]. Chin Med J (Engl), 2021, 134(18):2214-2222. doi:10.1097/CM9.0000000000001530.